Evidence map›Paper›PMID 42285976›Full record

ArticleHuman genome variation2026

Post-mortem diagnosis of CACT deficiency with a novel SLC25A20 variant.

Hiromi Nyuzuki, Aya Miura, Takuma Yamamoto, Akihide Koyama, Kazuhisa Funayama, Satoru Takami, Saori Fujita, Youko Kuriyama, Hisakazu Takatsuka, Hajime Nishio and 1 more

Abstract read
In one paragraph

Article in Human genome variation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hiromi Nyuzuki *Center for Medical Genetics, Niigata University Medical and Dental Hospital, Niigata, Japan. nyuzuki@med.niigata-u.ac.jp.ORCID http://orcid.org/0000-0003-1502-0875
Aya Miura *Department of Legal Medicine, Hyogo Medical University, Hyogo, Japan.
Takuma YamamotoDepartment of Legal Medicine, Hyogo Medical University, Hyogo, Japan.
Akihide KoyamaDivision of Forensic Medicine, Niigata University Graduate School of Medicine, Dentistry and Health Sciences, Niigata, Japan.
Kazuhisa FunayamaDivision of Forensic Medicine, Niigata University Graduate School of Medicine, Dentistry and Health Sciences, Niigata, Japan.
Satoru TakamiDepartment of Pediatrics, Saiseikai Niigata Hospital, Niigata, Japan.
Saori FujitaCenter for Medical Genetics, Niigata University Medical and Dental Hospital, Niigata, Japan.
Youko KuriyamaCenter for Medical Genetics, Niigata University Medical and Dental Hospital, Niigata, Japan.
Hisakazu TakatsukaDivision of Forensic Medicine, Niigata University Graduate School of Medicine, Dentistry and Health Sciences, Niigata, Japan.
Hajime NishioDepartment of Legal Medicine, Hyogo Medical University, Hyogo, Japan.
Takeshi IkeuchiCenter for Medical Genetics, Niigata University Medical and Dental Hospital, Niigata, Japan.ORCID http://orcid.org/0000-0001-8828-8085

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carnitine-acylcarnitine translocase deficiency is a severe neonatal metabolic disorder caused by SLC25A20 variants. We report a case of sudden neonatal death in which post-mortem CT revealed diffuse fatty liver, and subsequent genetic analysis identified compound heterozygous variants in SLC25A20, including a known variant, c.824G>A p.(Arg275Gln), and a novel nonsense variant, c.334C>T p.(Gln112Ter). These findings demonstrate the utility of post-mortem genetic analysis in determining the cause of sudden neonatal death.

Identifiers

PMID42285976
PMCPMC13538503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.